1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Ruige Pharmaceutical

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

Shanghai China

Primary Industry

Pharmaceuticals

About

Established in 2018 and based in Shanghai, China, Ruige Pharmaceutical is a medical company that focuses on the research and development of drugs in the field of tumors, autoimmunity and metabolism. The company engages in the research and development of drugs. It has a CARD technology platform that combines structural biology, computational chemistry, medicinal chemistry and biology. The CARD technology platform provides drug research and development services.
Current Investors
Qilu Pharmaceuical, Lilly Asia Ventures, Vertex Ventures China

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.regor.com
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo